News RS Oncology Announces Completion of First-in-Human Phase 1 Clinical Trial of RSO-021, a Novel Irreversible Inhibitor of Mitochondrial PRX3 Sep 12, 2023 Posted by RS Oncology LLC
News BioIVT Completes XenoTech Integration, Highlights Expanded ADME-Tox Research Services at the North American ISSX Meeting Sep 07, 2023 Posted by BioIVT
Case Studies Expedite Training, Technical Support, and Lab Design by Leveraging Mixed Reality Sep 06, 2023
News Skeletal editing and removing the gap between CADD/AIDD and synthesis Sep 05, 2023 Posted by Cresset
News Greenberg Traurig’s Melissa Hunter-Ensor and Chia-Feng Lu Shortlisted for LMG Life Sciences 2023 Americas Awards Aug 29, 2023 Posted by Greenberg Traurig, LLP
News Sounds of Science Podcast – Episode 17 on Real-World Evidence (RWE) Aug 24, 2023 Posted by European Confederation of Pharmaceutical Entrepreneurs (EUCOPE)